Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Enliven Inc.”

3 pharma patents match "Enliven Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "Enliven Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “Enliven Inc.” · 30,257 patents in full index Clear search

  1. US 12240846

    5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases

    Enliven Inc. · Granted Mar 4, 2025 · Expires Feb 27, 2045

    granted
  2. US 11807638

    5- and 6-azaindole compounds for inhibition of Bcr-Abl tyrosine kinases

    Enliven Inc. · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted
  3. US 11767321

    5- and 6-azaindole compounds for inhibition of BCR-ABL tyrosine kinases

    Enliven Inc. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted